Physician profile
Jenna Shock
NPI 1255984738
$2,344.98
in general payments reported to CMS, 2019-2025
17 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $968 · 2022: $1,079 · 2024: $16.59 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $391.17 | 2021-2025 | Fanapt |
| Abbvie INC. | $359.06 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $259.48 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $225.57 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $225.11 | 2021-2022 | |
| Lundbeck LLC | $176.09 | 2021-2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $95.04 | 2022 | |
| Alkermes, INC. | $94.72 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $91.39 | 2021-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $87.83 | 2021-2022 | |
| Adlon Therapeutics L.P. | $87.51 | 2021 | |
| Corium, LLC | $80.64 | 2022 | |
| Eisai INC. | $69.40 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $41.90 | 2021-2022 | |
| Noven Therapeutics, LLC | $21.30 | 2025 | Xelstrym |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $20.03 | 2021 | |
| Tris Pharma INC | $18.74 | 2025 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Shock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.